 PIOMBINO DESE, Italy--BUSINESS WIRE--Stevanato Group S.p.A. NYSE: STVN, a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the second quarter 2021 and established full-year 2021 guidance. Second Quarter 2021 Highlights compared to the same period last year and Guidance Revenue grew 26 to 204.0 million; all growth was organic Gross margins incr 